Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney diseases

NDT Plus

Volumn 2, Issue 2, 2009, Pages 192-193

  Takenaka, Tsuneo ^a   Takane, Hiroshi ^a   Okada, Hirokazu ^a   Ohno, Yoichi ^a   Suzuki, Hiromichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BENIDIPINE; CALCIUM ANTAGONIST; CALCIUM CHANNEL L TYPE; INOSITOL TRISPHOSPHATE; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ARTERIAL STIFFNESS; ARTERY COMPLIANCE; AUGMENTATION INDEX; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DRUG MECHANISM; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 70350045749     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfp014     Document Type: Letter

References (5)

1. Takenaka T, Mimura T, Kanno Yet al.Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases. Am J Nephrol 2005; 25: 417-424
2. Mimura T, Takenaka T, Kanno Y et al. Vascular compliance is secured under angiotensin inhibition in non-diabetic chronic kidney diseases. J Hum Hypertens 2008; 22: 38-47
3. 2+ channels in renal microcirculation. J Pharmacol Sci 2005; 99: 221-227
4. Takenaka T, Suzuki H, Okada H et al. Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II. Kidney Int 2002; 62: 558-565
5. Günther W, Lüchow A, Cluzeaud F et al. ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci USA 1998; 95: 8075-8080